Accounting Estimates Reflecting the Impact of COVID-19
First written in FY2021-Q1. 6 of 13 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.
6 other companies' latest entry also says "Other".
- FY2026Updated the recoverability of deferred tax assetsAnnual report
「Current consolidated fiscal year Deferred tax assets ¥1,063.288 million」
The Company reviewed the recoverability of deferred tax assets and updated deferred tax assets from ¥948.993 million in the previous fiscal year to ¥1,063.288 million. - FY2025Reviewed the recoverability of deferred tax assets and recorded an additional amountAnnual report
「Profit attributable to owners of the parent was ¥1,076 million. Although the Company recognised an impairment loss of ¥252 million and an impairment loss on investment securities of ¥192 million, it recorded ¥(477) million in income taxes—deferred as a result of reviewing the recoverability of deferred tax assets and other factors.」
After reviewing the recoverability of deferred tax assets, deferred tax assets increased from ¥478.942 million to ¥948.993 million. The recognition of income taxes—deferred contributed to the increase in net income. - FY2024-Q3RestatedAnnual report
「There were no material changes to the assumptions, including the expected timing of the end of the COVID-19 pandemic, stated under “Significant Accounting Estimates” in the securities report for the previous consolidated fiscal year.」
The Company stated that there had been no material changes from the previous consolidated fiscal year in its accounting assumptions, including the expected timing of the end of the COVID-19 pandemic. - FY2024-Q1RestatedAnnual report
「There were no material changes to the assumptions, including the expected timing of the end of the COVID-19 pandemic, stated under “Significant Accounting Estimates” in the securities report for the previous consolidated fiscal year.」
The Company stated that there had been no material changes from the previous consolidated fiscal year in its accounting assumptions, including the expected timing of the end of the COVID-19 pandemic. - FY2023Updated accounting assumptions and impairment resultsAnnual report
「The Company expects COVID-19 to gradually subside as the balance between preventing the spread of infection and maintaining economic activity becomes established, and expects sales to recover.」
While continuing to apply accounting assumptions based on the gradual subsiding of the pandemic and a recovery in sales, the Company recognised an impairment loss of ¥327.429 million on store property, plant and equipment. - FY2023-Q2Extended the assumed period of the pandemic’s impactAnnual report
「The Company made partial changes to the assumptions, including the expected timing of the end of the COVID-19 pandemic, stated under “Significant Accounting Estimates” in the securities report for the previous consolidated fiscal year. It expects COVID-19 to gradually subside by around June 2024 as the balance between preventing the spread of infection and maintaining economic activity becomes established, with sales recovering gradually. There were no material changes to the other assumptions.」
The assumptions regarding the impact of the pandemic and the recovery in sales were changed in part from those for the previous consolidated fiscal year, with the assumed period extended to around June 2024. The Company stated that there were no material changes to the other assumptions. - FY2023-Q1RestatedAnnual report
「There were no material changes to the assumptions, including the expected timing of the end of the COVID-19 pandemic, stated under “Significant Accounting Estimates” in the securities report for the previous consolidated fiscal year.」
The Company stated that there had been no material changes from the previous consolidated fiscal year in its accounting assumptions, including the expected timing of the end of the COVID-19 pandemic. - FY2022Specified the accounting assumption for the expected end of the pandemicAnnual report
「The Company expects COVID-19 to gradually subside by around June 2023 as the balance between preventing the spread of infection and maintaining economic activity becomes established, and expects sales to recover. However, it assumes that sales at large-format stores will not return to pre-pandemic levels even after the pandemic subsides.」
As accounting assumptions used to value MBO goodwill and store property, plant and equipment, the Company specified that the pandemic would subside around June 2023 and sales would recover, while sales at large-format stores would not return to pre-pandemic levels. - FY2022-Q3RestatedAnnual report
「There were no material changes to the assumptions, including the expected timing of the end of the COVID-19 pandemic, stated under “Significant Accounting Estimates” in the securities report for the previous consolidated fiscal year.」
The Company reconfirmed that there had been no material changes in its accounting estimates concerning the expected timing of the end of the COVID-19 pandemic and related matters. - FY2022-Q1RestatedAnnual report
「There were no material changes to the assumptions, including the expected timing of the end of the COVID-19 pandemic, stated under “Significant Accounting Estimates” in the securities report for the previous consolidated fiscal year.」
The Company stated that there had been no material changes from the previous consolidated fiscal year in its accounting estimates concerning the expected timing of the end of the COVID-19 pandemic and related matters. - FY2021-Q3Extended the assumed impact periodAnnual report
「Based on these circumstances, the Company changed the assumption stated in the securities report for the previous consolidated fiscal year that the impact of COVID-19 would continue for approximately one year, and assessed impairment losses on property, plant and equipment and the recoverability of deferred tax assets on the basis that the impact would continue until around June 2022. Accordingly, during the nine months ended 31 December 2021, the Company recognised an impairment loss of ¥707.263 million on property, plant and equipment and recorded ¥901.819 million in income taxes—deferred as a result of writing down deferred tax assets.」
The previous assumption that the impact of the pandemic would continue for approximately one year was extended to around June 2022, resulting in the recognition of an impairment loss of ¥707.263 million and ¥901.819 million in income taxes—deferred. - FY2021-Q2RestatedAnnual report
「Based on these circumstances, the Company determined that, at this stage, there was no need to change the assumption stated in the securities report for the previous consolidated fiscal year that the impact of COVID-19 would continue for approximately one year. Accordingly, the Company assessed whether to recognise impairment losses on property, plant and equipment and the recoverability of deferred tax assets.」
The Company has maintained its accounting assumption that the impact of the pandemic would continue for approximately one year. Although the recovery in sales temporarily stalled after requests to shorten business hours from July onward, sales and operating profit gradually recovered from mid-September onward, according to the filing. - FY2021-Q1First statedAnnual report
「Based on these circumstances, the Company determined that, at this stage, there was no need to change the assumption stated in the securities report for the previous consolidated fiscal year that the impact of COVID-19 would continue for approximately one year. Accordingly, the Company assessed whether to recognise impairment losses on property, plant and equipment and the recoverability of deferred tax assets.」
The Company maintained its assumption that the impact of COVID-19 would continue for approximately one year and assessed the recognition of impairment losses on property, plant and equipment and the recoverability of deferred tax assets.